Influence of the phosphatidylethanolamine (PE) and bovine serum origins on anti-PE antibody detection by ELISA

Thrombosis Research

Volumn 85, Issue 5, 1997, Pages 439-442

  Berard, Madeleine ^a   Boffa, Marie Claire ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

antiphospholipid antibodies; bovine serum; ELISA; origin; phosphatidylethanolamine

Indexed keywords

PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COW; EGG YOLK; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; SERUM;

EID: 0031105384     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00032-7     Document Type: Article

References (14)

1. STAUB H.L., HARRIS E.N., KHAMASHTA M.A., SAVIDGE G., CHAHADE W.H., HUGHES G.R.V. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis. 48:1989;166-169.
2. KARMOCHKINE M., BERARD M., PIETTE J.C., CACOUB P., AILLAUD M.F., HARLE J.R., GODEAU P., BOFFA M.C. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus. 2:1993;157-160.
3. BERARD M., CHANTOME R., MARCELLI A., BOFFA M.C.I. Antiphosphatidyl-ethanolamine antibodies as the only antiphospholipid antibodies. Association with thrombosis and vascular cutaneous diseases. J Rheumatol. 23:1996;1369-1374.
4. SUGI T., McINTYRE J.A. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood. 86:1995;3083-3089.
5. BOFFA M.C., BERARD M., SUGI T., McINTYRE J.A. II. Antiphosphatidyl-ethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA: Kininogen reactivity. J Rheumatol. 23:1996;1375-1379.
6. 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome. J Autoimmun. 5:1992;787-801.
7. SMIRNOV M.D., TRIPLETT D.T., COMP P.C., ESMON N.L., ESMON C.T. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest. 95:1995;309-316.
8. SUGI T., McINTYRE J.A. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies. Thromb Haemost. 76:1996;354-360.
9. LE TONQUEZE M., DUEYMES M., GIOVANGRANDI Y., BEIGBEDER G., JOUQUAN J., PENNEC Y.L., MOTTIER D., LEGOFF P., YOUINOU P. The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Autoimmun. 20:1995;59-66.
10. FALCON C.R., HOFFER A.M., CARRERAS L.O. Evaluation of the clinical and laboratory associations of antiphosphatidylethanolamine. Thromb Res. 59:1990;383-388.
11. STERN J.J., RONALD H., TRIPLETT D.A., McINTYRE J.A. Incidence of antiphospholipid antibodies in patients with monoclonal gammapathy of undetermined significance. Am J Clin Pathol. 101:1994;471-474.
12. LAROCHE, P., BERARD, M., ROUQUETTE, A.M., DESGRUELLE, C. and BOFFA, M.C. Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies. Am J Clin Pathol in press, 1996.
13. SUGI T., McINTYRE J.A. Plasma proteins required for antiphospholipid antibody detection. Nouv Rev Fr Hematol. 37:(suppl II):1995;S49-S52.
14. WAGENKNECHT D.R., SUGI T., McINTYRE J.A. The evolution, evaluation and interpretation of antiphospholipid antibody assays. Clin Immunol News Lett. 15:1995;28-35.